¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"insulin-like activity substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mental activity
    Á¤½ÅȰµ¿
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • partial agonistic activity
    ºÎºÐÀÛ¿ëÁ¦È°¼º
  • specific activity
    1. ºñ¹æ»ç´É 2. ºñ(Ýï)Ȱ¼ºµµ, °íÀ¯È°¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • sexual activity
    ¼ºÈ°µ¿
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
  • cortical substance
    °ÑÁú, ÇÇÁú
  • crystalline substance
    °áÁ¤¹°Áú
  • cement substance
    Á¢ÇÕÁú, ½Ã¸àÆ®¹°Áú
  • chromophil substance
    È£»ö¼Òü, »ö¼Òģȭ¹°Áú
  • depressor substance
    °¨¾Ð¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molar activity
    ¸ôȰ¼º
  • partial agonistic activity
    ºÎºÐÈ¿´ÉȰ¼º
  • psychomotor activity
    Á¤½Å¿îµ¿È°µ¿
  • reflex gamma activity
    ¹Ý»ç°¨¸¶È°µ¿
  • sexual activity
    ¼ºÈ°µ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
  • spontaneous activity
    ÀÚ¹ßÀüÀ§
  • time-activity curve
    ½Ã°£¹æ»ç´É°î¼±
  • professional activity study
    Àü¹®°¡È°µ¿¿¬±¸
  • structure activity relationship
    ±¸Á¶È°¼º»ó°ü°ü°è, ±¸Á¶ÀÛ¿ë°ü°è
  • sperm activity grade test
    Á¤Àڿµî±Þ°Ë»ç
  • accelerans substance
    ÃËÁø¹°Áú
  • accessory food substance
    ºÎ¿µ¾ç¹°Áú
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • homosexual activity
    µ¿¼º¾ÖÀû ÇàÀ§
  • plasma histaminase activity
    Ç÷ÀåÈ÷½ºÅ¸¹Ì³ª¾ÆÁ¦È°¼ºµµ.
  • plasma renin activity
    Ç÷Àå·¹´ÑȰ¼ºµµ<--Ȱµ¿µµ>
  • psychomotor activity
    Á¤½Å¿îµ¿¼º Ȱµ¿.
  • realtive sepcific activity
    »ó´ëºñ¹æ»ç´É
  • C-substance
    C-¹°Áú.
  • EPS=£¾exophthalmos producing substance
    ¾È±¸µ¹ÃâÀ¯¹ß¹°Áú.
  • Goitrogenic substance
    °©»ó¼±Á¾À¯¹ß¹°Áú(Ë£ßÒàÍðþë¯Û¡Úªòõ)
  • Inducer substance
    À¯µµ¹°Áú(ë¯ÓôÚªòõ)
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • Kerry reducing substance test
    Äɸ®È¯¿ø¹°Áú½ÃÇè
  • Mullerian inhibiting substance
    ¹°·¯°ü ¾ïÁ¦¹°Áú
  • P substance
    P¹°Áú
  • SRS A : slow reacting substance A
    ¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • elastolytic activity
    ¿¤¶ó½ºÆ¾¿ëÇØÈ°¼º(µµ), ¿¤¶ó½ºÅ¸¾ÆÁ¦È°¼º(µµ).
  • enzyme activity
    È¿¼ÒȰ¼º
  • enzyme activity
    È¿¼ÒȰ¼ºµµ
  • epidemiologic activity
    ¿ªÇÐÀû Ȱµ¿(ËçÌ°Ëø Ì·ËÄ).
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • fusion activity
    À¶ÇÕ´É
  • glucagon activity
    ±Û·çÄ«°ïȰ¼ºµµ.
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÀû ÇàÀ§
  • insulin like activity =ILa
    Àν¶¸°¾çȰ¼º(ÀÛ¿ë).
  • intrinsic activity
    ¾à¸®³»ÀÎ<Àç>¼º Ȱ¼º.
  • intrinsic activity
    ³»È°¼º(Ò®üÀàõ).[¾à¸®]³»ÀÎ<Àç>¼º Ȱ¼º.
  • intrinsic sympathomimetic activity
    ³»Àμº ±³°¨½Å°æÀ¯»çÀÛ¿ë.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Intercellular substance
    ¼¼Æ÷»çÀ̹°Áú
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú¼¼Æ÷°£Áú
  • Lens substance
    ¼öÁ¤Ã¼¹°Áú
    [¿¾ ¿ë¾î] ¼öÁ¤Ã¼Áú
  • Neurosecretory substance
    ½Å°æºÐºñ¹°
    [¿¾ ¿ë¾î] ½Å°æºÐºñ¹°
  • Gelatinous substance
    ¾Æ±³Áú
    [¿¾ ¿ë¾î] ±³¾çÁú
  • Anterior perforated substance
    ¾Õ°üÅëÁú
    [¿¾ ¿ë¾î] ÀüÀ¯°øÁú
  • Central gelatinous substance
    Á߽ɾƱ³Áú
    [¿¾ ¿ë¾î] Á߽ɱ³¾çÁú
  • Central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£ÁúÁ߽ɺÎ
  • Central gray (substance)
    Áß½Éȸ»öÁú
    [¿¾ ¿ë¾î] Áß½Éȸ¹éÁú
  • Postacrosomal substance
    ÷´ÜüµÚ¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÈŰÁú
  • Postacrosomal substance
    ÷´ÜüµÚ¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÈÄÁú
  • Acrosomal substance
    ÷´Üü¹°Áú
    [¿¾ ¿ë¾î] ÷´Üü¹°Áú
  • Acrosomal substance
    ÷´Üü¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÁú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇϹ°Áú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇÏÁú
  • Substance of synaptic cleft
    Æ´»õ¹°Áú
    [¿¾ ¿ë¾î] ¿­³»Áú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • enzymatic activity
    È¿¼Ò Ȱ¼º (ý£áÈüÀàõ)
  • intrinsic activity
    ³»ÀçȰ¼º(Ò®î¤üÀàõ)
  • mean activity coefficient
    Æò±ÕȰµ¿°è¼ö(øÁгüÀÔÑͪâ¦)
  • mean ionic activity coefficient
    Æò±Õ(øÁг) ÀÌ¿ÂȰ¼º°è¼ö(üÀàõͪâ¦)
  • molar activity
    ¸ô Ȱ¼º(üÀàõ)
  • molecular activity
    ºÐÀÚȰ¼º(ÝÂí­üÀàõ)
  • myotropic activity
    ±Ù°­È­È°¼º(ÐÉË­ûùüÀàõ)
  • optical activity
    ±¤ÇРȰ¼º(ÎÃùÊüÀàõ)
  • Raman optical activity
    ¶ó¸¸ ±¤ÇРȰ¼º(µµ)(ÎÃùÊüÀàõ(Óø))
  • relative specific activity
    »ó´ë ƯÀÌ È°¼ºµµ(ßÓÓß÷åì¶üÀàõÓø)
  • specific activity
    ºñȰ¼º(ÝïüÀàõ)
  • suppressible insulin-like activity
    ¾ï¾Ð °¡´É(åääâʦÒö) Àν¶¸°À¯»çȰ¼º(×¾ÞÄüÀàõ)
  • surface activity
    Ç¥¸éȰ¼º (øúØüüÀàõ)
  • vibrational optical activity
    Áøµ¿ ±¤ÇРȰ¼º(òÉÔÑÎÃùÊ üÀàõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MIS management information system; medical information service; meiosis-inducing substance; minimally in...
SAS sarcoma amplified sequence; self-rating anxiety scale; short arm splint; Sklar Aphasia Scale; sleep ...
CIA chemiluminescent immunoassay; chymotrypsin inhibitor activity; colony-inhibiting activity; congenita...
ECA electrical control activity; electrocardioanalyzer; endothelial cytotoxic activity; enterobacterial ...
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DLIS Digoxin-like immunoreactive substance
EDLS Endogenous digitalis-like substance
HSS Hepatic Stimulatory Substance
I-SP Immunoreactive substance P
ir SP Immunoreactive substance P
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intercellular substance
    ¼¼Æ÷ °£Áú, ¼¼Æ÷°£ ¹°Áú
    ¼¼Æ÷¿Í ¼¼Æ÷ »çÀ̸¦ ä¿ì´Â ¹°Áú. ±âÁúÀ̶ó°íµµ ÇÑ´Ù. ÁÖµÈ ¼ººÐÀº È÷¾Ë¿ì·Ð»êÀ̳ª Äܵå·ÎÀÌÆ¾ Ȳ»ê µîÀÇ Á¡¾× ´Ù´çÀ» ÁÖ·ÎÇÏ´Â ´Ü¹éÁú ´Ù´çÀÌ´Ù. »À Á¶Á÷¿¡¼­´Â Ä®½· ¿°, ¸¶±×³×½· ¿°À» ¼¼Æ÷°£ ¹°Áú·Î¼­ ÇÔÀ¯Çϰí ÀÖ´Ù.
  • lateral intermediate substance
    °¡ÂÊ Áß°£ ȸ»öÁú
  • lens substance
    ¼öÁ¤Ã¼ ¹°Áú, ¼öÁ¤Ã¼ Áú
  • medullary substance
    ¼öÁú
    Ãà»è°ú ¼öÃʸ¦ ÀÌ·ç´Â ÁßÃ߽Űæ°èÀÇ ¹éÁú. ±â°ü ³»ºÎÀÇ À¯¿¬ÇÑ °ñ¼ö¾ç ¹°Áú.
  • nutrient substance
    ¿µ¾ç ¹°Áú
  • odoriferous substance
    Çâ·á
  • osteoid substance
    Dz »À ¹°Áú
  • pain producing substance
    µ¿Åë À¯¹ß ¹°Áú
  • psychoactive substance-induced organic mental disorder
    ȰÁ¤½Å¼º ¹°Áú·Î À¯µµµÈ ±âÁúÀû Á¤½Å Àå¾Ö
    ȰÁ¤½Å¼º ¹°ÁúÀÇ »ç¿ë°ú °ü·ÃµÈ ±âÁúÀû ³ú ÁõÈÄ. ¿­ °¡Áö Ư¼ö ÁõÈĸ¦ Æ÷ÇÔÇϰí Àִµ¥ Áßµ¶, Áß´Ü Áõ»ó, ¼¶¸Á, Ä¡¸Å, °Ç¸Á Àå¾Ö, ¸Á»ó Àå¾Ö, ȯ°¢, °¨Á¤ Àå¾Ö, Áö°¢ Àå¾Ö ¹× ÀÎ°Ý Àå¾Ö µîÀÌ´Ù. ¾ËÄÝ Áßµ¶°ú °°ÀÌ ¿øÀÎ ¹°ÁúÀÌ ¾Ë·ÁÁ® ÀÖÀ¸¸é À̸¦ ¸í±âÇÑ´Ù.
  • radioactive substance
    ¹æ»ç¼º ¹°Áú
  • receptive substance
    ¼ö¿ë ¹°Áú
    ±ÙÀ° Á¶Á÷, ƯÈ÷ ½Å°æÀÇ ¿îµ¿ Á¾ÆÇ ±Ùó¿¡ ÀÖÀ¸¸ç ÈïºÐÀ» ÀüµµÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ´Â ¹°Áú.
  • slow-reating substance
    Áö¹ÝÀÀ¼º ¹°Áú
    ¾î¶² ÆòȰ±ÙÀÇ ´À¸®°í Áö¼Ó¼ºÀÎ ¼öÃàÀ» ÀÏÀ¸Å°´Â ¾Æ³ªÇʶô½Ã ¹ÝÀÀ ½Ã¿¡ ¹æÃâµÇ´Â ¹°Áú ±âÈ£ SRS-A.
  • substance defect
    ¹°Áú °áÇÌ
  • substance P fiber
    P ¹°Áú ¼¶À¯
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
nonsuppressible insulin-like activity A blood protein (nsila) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of cohn fraction III, 10% of the activity is found in the supernatant (nsila-s) and the remaining activity in the precipitate (nsila-p). The latter is a large molecular compound, much less stable than the soluble fraction. Nsila-s is a more potent growth factor than insulin and exhibits sulfation activity.
(12 Dec 1998)
drug activity A measure of the physiological response a drug produces. A less active drug produces less response (and visa versa).
(12 Dec 1998)
insulin-like activity A measure of substances, usually in plasma, that exert biologic effects similar to those of insulin in various bioassays; sometimes used as a measure of plasma insulin concentrations; always gives higher values than immunochemical techniques for the measurement of insulin.
(05 Mar 2000)
intrinsic sympathomimetic activity The property of a drug that causes activation of adrenergic receptors so as to produce effects similar to stimulation of the sympathetic nervous system.
(05 Mar 2000)
optical activity The ability of a material to rotate the plane of polarized light.
(09 Oct 1997)
triggered activity One or a series of spontaneously generated heart beats originating from an action potential that produces an after-depolarisation which reaches activation threshold.
(05 Mar 2000)
unit of thyrotrophic activity The activity of an amount of an extract of the anterior lobe of the hypophysis which, given daily for 5 days, will cause the thyroid of a guinea pig (weighing 200 g) to reach a weight of 600 mg.
(05 Mar 2000)
zone of polarizing activity <cell biology> The small group of mesenchyme cells in avian limb buds that is located at the posterior margin of the developing bud and that produces a substance, possibly retinoic acid, that provides positional information to the developing limb bud.
(18 Nov 1997)
alpha substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
anterior perforated substance A region at the base of the brain through which numerous small branches of the anterior and middle cerebral arteries (lenticulostriate arteries) enter the depth of the cerebral hemisphere; it is bordered medially by the optic chasm and anterior half of the optic tract, rostrally and laterally by the lateral olfactory stria; its anteromedial part corresponds to the olfactory tubercle.
Synonym: substantia perforata anterior, locus perforatus anticus, olfactory area.
(05 Mar 2000)
autacoid substance A substance formed metabolically by one set of cells, which alters the function of other cells. (This term is sometimes used in place of the term hormone.)
(05 Mar 2000)
bacteriotropic substance Opsonin or other substance that alters bacterial cells in such a manner that they are more susceptible to phagocytic action.
(05 Mar 2000)
basophilic substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
basophil substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
blood group substance Blood group-specific substances A and B, solution of complexes of polysaccharides and amino acids that reduces the titre of anti-A and anti-B isoagglutinins in serum from group O persons; used to render group O blood reasonably safe for transfusion into persons of group A, B, or AB, but does not affect any incompatibility that results from various other factors, such as Rh.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á